You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
麗珠醫藥(01513.HK)參股天津同仁堂IPO因會計師受查申請審覈中止
麗珠醫藥(01513.HK)公佈,公司參股公司因「天津同仁堂」首次公開發行股票並在創業板上市(IPO)聘請的會計師信永中和會計師事務所被中國證監會立案調查,深交所於上月26日中止天津同仁堂本次發行上市審覈。 公司表示,天津同仁堂IPO申請審覈中止,不會對公司生產經營活動產生重大影響,天津同仁堂將根據要求儘快履行相關程序並向深交所申請恢復對本次申請的審查,其IPO申請的恢復審查時間及最終能否獲得深交所的核準尚存在不確定性。 公司去年3月向天津天士力收購天津同仁堂40%股權,現金代價7.24億元人民幣。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account